Navigation Links
New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation
Date:3/5/2009

DALLAS, March 5 /PRNewswire/ -- A study published by Deborah S. Sarnoff, M.D. et al in the February issue of the Journal of Drugs in Dermatology explores the new generation of carbon dioxide (CO2) laser skin resurfacing technologies, specifically, the SmartXide DOT(TM) laser. DOT utilizes a fractional or microablative approach to treating the skin allowing for rapid healing, less downtime and profound results. Dr. Sarnoff is a board certified dermatologist and clinical professor of Dermatology at NYU Medical Center.

As consumers have become savvier to skin care and laser options, the pendulum is swinging back to more result-oriented treatments. With the saturation of non-ablative lasers, skin tightening devices and chemical peels, patients are looking for an alternative treatment that offers exceptional results with fewer treatments and less time in the doctor's office. What these procedures can do in 4-5 treatments, the DOT technology can do in a single treatment and results have been far superior to anything on the market today.

By combining the CO2 laser with a fractionated technique, the latest innovation in skin rejuvenation, DOT (Dermal Optical Thermolysis), has become the optimal choice for active patients desiring significant effects from a single treatment with minimal downtime. Additionally, DOT Therapy is ideal in causing immediate contraction of wrinkles and loose skin, results that non-ablative lasers produce in a time span of about six months.

Dr. Sarnoff's study examined 32 patients ages 33-76 over a six-month period who underwent a single laser resurfacing procedure with the DOT technology. Areas treated included the face, neck, trunk and hands. Results demonstrated over 50% improvement in almost all of the patients. Those treated for wrinkles, hyperpigmentation and sun damage showed over 75% improvement.

Why It Works

The D
'/>"/>

SOURCE Eclipsemed
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
2. Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss
3. Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved
4. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
5. TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee
6. Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study
7. Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds
8. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
9. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
10. Childrens Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia
11. MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015   Leatt Corporation  (OTCQB: LEAT), a ... for all forms of sports, including extreme motor sports, ... announced today that the UISP Lega Motociclismo Lombardia, an ... riders to wear a neck brace during its racing ...
(Date:1/23/2015)... LONDON and BOSTON , January ... structure-guided drug discovery and development company, is delighted to announce ... has been awarded to Miles Congreve (Vice President ... co-founder) and Malcolm Weir (Chief Executive Officer and ...
(Date:1/22/2015)... UPI ), a medical device company that develops, manufactures ... today reported financial results for the fiscal 2015 third ... the Company,s Urgent ®  PC Neuromodulation System grew 14.5% ... compared to $3.9 million in the third quarter of ...
Breaking Medicine Technology:Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18
... Further analysis of Phase III trial data ... treatment of post-operative,pain , CAMBRIDGE, England, 7th ... the Cambridge based biopharmaceutical company today,announces additional ... (M6G022),of M6G (morphine-6-glucuronide) in over 500 patients ...
... Reduction in Intestinal Adenomas Suggesting,Possible Beneficial Mediation in ... March 07, 2007 /PRNewswire/ -- NutraCea,announced today the ... rice bran,on the number of intestinal adenomas in ... edition of the prestigious British,Journal of Cancer conducted ...
Cached Medicine Technology:CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 2CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 3CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 4CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 5CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 6CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 7British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 2British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 3British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 4
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the main ... , Auto insurance quotes help many drivers find the ... to call an agent or visit an agency for price ... website: http://autocarinsurancebest.com/ . , Every business who relies heavily ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Carinsurancesavings.biz has released ... accidental death and dismemberment insurance . , Purchasing an ... can be very advantageous. This type of rider provides benefits ... dismemberment can be considered a lesser form of life insurance. ...
(Date:1/22/2015)... A study recently published in ... Medicine & Science in Sports & Exercise shows ... reduce gastrointestinal (GI) problems associated with physical strain ... the double-blind, placebo-controlled study took 10 grams of ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... annual revenues in the past three years. Today, the business ... , According to the sales manager of the company, this ... in 2015. This point can be reflected on the discounted ...
(Date:1/22/2015)... Colorado (PRWEB) January 22, 2015 Four years since ... Queen – which coincided with the marriage of Avasa & Matthew ... THE ROAD, which is scheduled for release through White Swan Records ... message that there is a sacred path available to all of ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... those who take up the habit , , FRIDAY, May 9 ... in their everyday conversations with peers helps reduce smoking rates, ... study included almost 11,000 students, ages 12 to 13, at ... the schools, certain students were selected to receive training about ...
... May 9 Alseres,Pharmaceuticals, Inc. (Nasdaq: ALSE ... call on Thursday, May 15th, 2008 at 9:00am ... 2008 and discuss other matters related to,the Company., ... access the conference call, please dial 877-795-3649 for ...
... 9 Xmark Opportunity Partners,LLC, the investment manager ... and Xmark JV Investment Partners, LLC, announced,today that ... press release,issued by Genaera Corporation (Nasdaq: GENR ... base compensation, cash incentives to executives, workforce,reduction and ...
... standardization, ... and reduces costs, IRVINE, Calif., May 9 ... of Pulse CO-Oximetry and,Measure-Through-Motion-and-Low-Perfusion Pulse Oximetry, have announced ... Masimo SET pulse oximetry. The New Jersey-based hospital ...
... groups to reach,stricken Myanmar, EVANSTON, Ill., May ... to cyclone ravaged Myanmar, among the first,charities actually ... grassroots,disaster relief organization supported by Rotary clubs around ... volunteers was on the ground Thursday (May,8) preparing ...
... fruits and vegetables reduced brain plaques in mouse experiments ... found in many fruits and vegetables, may be able ... study suggests. , In experiments with mice, two flavonoids ... forms the harmful plaques that build up in the ...
Cached Medicine News:Health News:Training Student Leaders Cuts Peers' Smoking Rates 2Health News:Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call 2Health News:Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call 3Health News:Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry 2Health News:Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry 3Health News:Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry 4Health News:Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry 5Health News:Rotary Clubs Provide Emergency Shelters, Supplies to Cyclone Victims 2Health News:Flavonoids May Help Treat Alzheimer's 2Health News:Flavonoids May Help Treat Alzheimer's 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: